Clinical Trial to Assess Bioequivalence of Lazertinib Between Two Formulations in Healthy Volunteers.

NCT05162274 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Volunteers

Interventions

DRUG: Lazertinib(G001)
DRUG: Lazertinib(G002)

Sponsor

Yuhan Corporation